The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nitroglycerin for Angina-Global Market Insights and Sales Trends 2025
Synopsis
Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
The global Nitroglycerin for Angina market size is expected to reach US$ 505.1 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Nitroglycerin for Angina in various end use industries. The expanding demands from the Relief and Prophylaxis, are propelling Nitroglycerin for Angina market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nitroglycerin for Angina, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nitroglycerin for Angina market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nitroglycerin for Angina market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nitroglycerin for Angina sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nitroglycerin for Angina covered in this report include Pfizer, Espero Pharmaceuticals, Us Pharma, Mylan, Sandoz, Hercon Pharmaceuticals, Glenmark, Sigmapharm Laboratories and Dr. Reddy's Laboratories, etc.
The global Nitroglycerin for Angina market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Espero Pharmaceuticals
Us Pharma
Mylan
Sandoz
Hercon Pharmaceuticals
Glenmark
Sigmapharm Laboratories
Dr. Reddy's Laboratories
Global Nitroglycerin for Angina market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nitroglycerin for Angina market, Segment by Type:
Tablet
Powder
Transdermal
Global Nitroglycerin for Angina market, by Application
Relief
Prophylaxis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nitroglycerin for Angina in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
The global Nitroglycerin for Angina market size is expected to reach US$ 505.1 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Nitroglycerin for Angina in various end use industries. The expanding demands from the Relief and Prophylaxis, are propelling Nitroglycerin for Angina market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nitroglycerin for Angina, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nitroglycerin for Angina market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nitroglycerin for Angina market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nitroglycerin for Angina sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nitroglycerin for Angina covered in this report include Pfizer, Espero Pharmaceuticals, Us Pharma, Mylan, Sandoz, Hercon Pharmaceuticals, Glenmark, Sigmapharm Laboratories and Dr. Reddy's Laboratories, etc.
The global Nitroglycerin for Angina market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Espero Pharmaceuticals
Us Pharma
Mylan
Sandoz
Hercon Pharmaceuticals
Glenmark
Sigmapharm Laboratories
Dr. Reddy's Laboratories
Global Nitroglycerin for Angina market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nitroglycerin for Angina market, Segment by Type:
Tablet
Powder
Transdermal
Global Nitroglycerin for Angina market, by Application
Relief
Prophylaxis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nitroglycerin for Angina in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Nitroglycerin for Angina Market Overview
1.1 Nitroglycerin for Angina Product Overview
1.2 Nitroglycerin for Angina Market Segment by Type
1.2.1 Tablet
1.2.2 Powder
1.2.3 Transdermal
1.3 Global Nitroglycerin for Angina Market Size by Type
1.3.1 Global Nitroglycerin for Angina Market Size Overview by Type (2018-2029)
1.3.2 Global Nitroglycerin for Angina Historic Market Size Review by Type (2018-2023)
1.3.3 Global Nitroglycerin for Angina Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nitroglycerin for Angina Sales Breakdown by Type (2018-2023)
1.4.2 Europe Nitroglycerin for Angina Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Nitroglycerin for Angina Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Nitroglycerin for Angina Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Nitroglycerin for Angina Sales Breakdown by Type (2018-2023)
2 Global Nitroglycerin for Angina Market Competition by Company
2.1 Global Top Players by Nitroglycerin for Angina Sales (2018-2023)
2.2 Global Top Players by Nitroglycerin for Angina Revenue (2018-2023)
2.3 Global Top Players by Nitroglycerin for Angina Price (2018-2023)
2.4 Global Top Manufacturers Nitroglycerin for Angina Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nitroglycerin for Angina Market Competitive Situation and Trends
2.5.1 Nitroglycerin for Angina Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Nitroglycerin for Angina Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nitroglycerin for Angina as of 2022)
2.7 Date of Key Manufacturers Enter into Nitroglycerin for Angina Market
2.8 Key Manufacturers Nitroglycerin for Angina Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nitroglycerin for Angina Status and Outlook by Region
3.1 Global Nitroglycerin for Angina Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Nitroglycerin for Angina Historic Market Size by Region
3.2.1 Global Nitroglycerin for Angina Sales in Volume by Region (2018-2023)
3.2.2 Global Nitroglycerin for Angina Sales in Value by Region (2018-2023)
3.2.3 Global Nitroglycerin for Angina Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Nitroglycerin for Angina Forecasted Market Size by Region
3.3.1 Global Nitroglycerin for Angina Sales in Volume by Region (2024-2029)
3.3.2 Global Nitroglycerin for Angina Sales in Value by Region (2024-2029)
3.3.3 Global Nitroglycerin for Angina Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Nitroglycerin for Angina by Application
4.1 Nitroglycerin for Angina Market Segment by Application
4.1.1 Relief
4.1.2 Prophylaxis
4.2 Global Nitroglycerin for Angina Market Size by Application
4.2.1 Global Nitroglycerin for Angina Market Size Overview by Application (2018-2029)
4.2.2 Global Nitroglycerin for Angina Historic Market Size Review by Application (2018-2023)
4.2.3 Global Nitroglycerin for Angina Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nitroglycerin for Angina Sales Breakdown by Application (2018-2023)
4.3.2 Europe Nitroglycerin for Angina Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Nitroglycerin for Angina Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Nitroglycerin for Angina Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Nitroglycerin for Angina Sales Breakdown by Application (2018-2023)
5 North America Nitroglycerin for Angina by Country
5.1 North America Nitroglycerin for Angina Historic Market Size by Country
5.1.1 North America Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Nitroglycerin for Angina Sales in Volume by Country (2018-2023)
5.1.3 North America Nitroglycerin for Angina Sales in Value by Country (2018-2023)
5.2 North America Nitroglycerin for Angina Forecasted Market Size by Country
5.2.1 North America Nitroglycerin for Angina Sales in Volume by Country (2024-2029)
5.2.2 North America Nitroglycerin for Angina Sales in Value by Country (2024-2029)
6 Europe Nitroglycerin for Angina by Country
6.1 Europe Nitroglycerin for Angina Historic Market Size by Country
6.1.1 Europe Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Nitroglycerin for Angina Sales in Volume by Country (2018-2023)
6.1.3 Europe Nitroglycerin for Angina Sales in Value by Country (2018-2023)
6.2 Europe Nitroglycerin for Angina Forecasted Market Size by Country
6.2.1 Europe Nitroglycerin for Angina Sales in Volume by Country (2024-2029)
6.2.2 Europe Nitroglycerin for Angina Sales in Value by Country (2024-2029)
7 Asia-Pacific Nitroglycerin for Angina by Region
7.1 Asia-Pacific Nitroglycerin for Angina Historic Market Size by Region
7.1.1 Asia-Pacific Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Nitroglycerin for Angina Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Nitroglycerin for Angina Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Nitroglycerin for Angina Forecasted Market Size by Region
7.2.1 Asia-Pacific Nitroglycerin for Angina Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Nitroglycerin for Angina Sales in Value by Region (2024-2029)
8 Latin America Nitroglycerin for Angina by Country
8.1 Latin America Nitroglycerin for Angina Historic Market Size by Country
8.1.1 Latin America Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Nitroglycerin for Angina Sales in Volume by Country (2018-2023)
8.1.3 Latin America Nitroglycerin for Angina Sales in Value by Country (2018-2023)
8.2 Latin America Nitroglycerin for Angina Forecasted Market Size by Country
8.2.1 Latin America Nitroglycerin for Angina Sales in Volume by Country (2024-2029)
8.2.2 Latin America Nitroglycerin for Angina Sales in Value by Country (2024-2029)
9 Middle East and Africa Nitroglycerin for Angina by Country
9.1 Middle East and Africa Nitroglycerin for Angina Historic Market Size by Country
9.1.1 Middle East and Africa Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Nitroglycerin for Angina Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Nitroglycerin for Angina Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Nitroglycerin for Angina Forecasted Market Size by Country
9.2.1 Middle East and Africa Nitroglycerin for Angina Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Nitroglycerin for Angina Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Nitroglycerin for Angina Products Offered
10.1.5 Pfizer Recent Development
10.2 Espero Pharmaceuticals
10.2.1 Espero Pharmaceuticals Company Information
10.2.2 Espero Pharmaceuticals Introduction and Business Overview
10.2.3 Espero Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Espero Pharmaceuticals Nitroglycerin for Angina Products Offered
10.2.5 Espero Pharmaceuticals Recent Development
10.3 Us Pharma
10.3.1 Us Pharma Company Information
10.3.2 Us Pharma Introduction and Business Overview
10.3.3 Us Pharma Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Us Pharma Nitroglycerin for Angina Products Offered
10.3.5 Us Pharma Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Nitroglycerin for Angina Products Offered
10.4.5 Mylan Recent Development
10.5 Sandoz
10.5.1 Sandoz Company Information
10.5.2 Sandoz Introduction and Business Overview
10.5.3 Sandoz Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sandoz Nitroglycerin for Angina Products Offered
10.5.5 Sandoz Recent Development
10.6 Hercon Pharmaceuticals
10.6.1 Hercon Pharmaceuticals Company Information
10.6.2 Hercon Pharmaceuticals Introduction and Business Overview
10.6.3 Hercon Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Hercon Pharmaceuticals Nitroglycerin for Angina Products Offered
10.6.5 Hercon Pharmaceuticals Recent Development
10.7 Glenmark
10.7.1 Glenmark Company Information
10.7.2 Glenmark Introduction and Business Overview
10.7.3 Glenmark Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Glenmark Nitroglycerin for Angina Products Offered
10.7.5 Glenmark Recent Development
10.8 Sigmapharm Laboratories
10.8.1 Sigmapharm Laboratories Company Information
10.8.2 Sigmapharm Laboratories Introduction and Business Overview
10.8.3 Sigmapharm Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sigmapharm Laboratories Nitroglycerin for Angina Products Offered
10.8.5 Sigmapharm Laboratories Recent Development
10.9 Dr. Reddy's Laboratories
10.9.1 Dr. Reddy's Laboratories Company Information
10.9.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.9.3 Dr. Reddy's Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dr. Reddy's Laboratories Nitroglycerin for Angina Products Offered
10.9.5 Dr. Reddy's Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nitroglycerin for Angina Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nitroglycerin for Angina Industrial Chain Analysis
11.4 Nitroglycerin for Angina Market Dynamics
11.4.1 Nitroglycerin for Angina Industry Trends
11.4.2 Nitroglycerin for Angina Market Drivers
11.4.3 Nitroglycerin for Angina Market Challenges
11.4.4 Nitroglycerin for Angina Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nitroglycerin for Angina Distributors
12.3 Nitroglycerin for Angina Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
